Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
By T. Moore, S. Zammit, A. Lingford-Hughes, T. Barnes, Peter B. Jones, M. Burke, G. Lewis. The Lancet, 2007
2,201 citations recorded by the source corpus.
Subfields: Clinical Psychology, Epidemiology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/41eba6799008f0ec7db7ff718a7564b5c373cc22
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
In Epidemiology
In Pharmacology
Citations in the corpus
- The dopamine hypothesis of schizophrenia: version III--the final common pathway. (2009, positive): “Since earlier versions of the dopamine hypothesis, cannabis use has emerged as a risk factor for schizophrenia.(92,93)”
- Is cannabis use normalized, celebrated or neutralized? Analysing talk as action (2012, background): “Macro-studies that have revealed a causal link between cannabis and schizophrenia have received much attention in the media in recent years (Moore et al., 2007).”
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology (2010, background): “In patients with schizophrenia, D-9-THC may exacerbate existing psychotic symptoms, anxiety and memory impairments (D'Souza et al, 2005), and D-9-THC is thought to be the ingredient responsible for the increased risk of developing schizophrenia following regular cannabis use (Moore et al, 2007).”
- A ‘standard joint’? The role of quantity in predicting cannabis-related problems (2012, background): “…(Diplock & Plecas, 2009; Moore, Augustson, Moser, & Budney, 2005; Taylor & Hall, 2003), psychotic disorders and impaired cognitive functioning (Moore et al., 2007; Porath-Waller, 2009) as well as psychosocial effects such as impaired educational attainment in adolescents, and an increased…”
- Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and six months (2008, background): “…2006; Hayatbakhsh et al., 007; Howard et al., 2004; Macdonald et al., 2003; McFadden t al., 2005; Mertens et al., 2003, 2005; Moore et al., 2007; yenwe et al., 2007; O’Malley and Johnston, 2003; Rivara t al., 1997; Rootman et al., 2007; Shoptaw and Reback, 007; Stein and Friedmann, 2006;…”